Digital

During his 40 years at Royal Philips, Bert van Meurs has seen the medical devices business grow in line with the evolving needs of healthcare providers with whom the company partners in customer and patient focused innovation.

Simultaneous revisions of the EU’s AI, data and medtech rules offer opportunities for simplification and alignment but also risk confusion and competing priorities. With political tensions in the background, does all this portend further unwanted compromises or delays for medtech?

The European Commission’s Digital Omnibus Package promises to simplify EU complex digital compliance processes, but is it taking the EU in the right direction in its simplification efforts?

The European Commission seems to have heeded many of the medtech industry’s points regarding challenges with the implementation of the AI Act within the Digital Omnibus. But the usual EU hurdles must be crossed before the sector will know if these proposals will make it into law.

How will medtech be buffeted by what is seen as the EU’s capitulation to US demands to water down its AI and data regulations?

Senior Indegene executive discusses why pharma R&D organizations of the future will need to be agile, modular and AI-native by design. Industry pilots are pointing the way to potential one click regulatory submissions.

MultiBurn supplement launch “is creating kind of a new focus I would say around weight loss, where quite honestly, we’ve been probably more of a healthy active lifestyle,” says CEO Stephan Gratziani. Pro2Col app for personalized wellness launching before January.

C-suite executives from Stryker, Intuitive Surgical and Fresenius passed a mainly upbeat verdict on the Indian medtech market and industry.

Studies and surveys “all point to one thing, that consumers don't understand nutrition,” says marketing consultant Stephen McCauley. Registered dieticians, including some with a nutrition specialty, are strong candidates to help health and wellness firms clear up the confusion.

C-suite executives from Stryker, Intuitive Surgical and Fresenius passed a mainly upbeat verdict on the Indian medtech market and industry. Their thoughts are encapsulated in part two of In Vivo’s APACMed 2025 conference review.

APACMed’s Asia-Pacific medtech forum moved outside Singapore for the first time in its 11-year history, to India, a country of big medtech ambitions and top five global market aspirations by 2035. This first In Vivo conference report describes India’s medtech infrastructure efforts.

Attorneys in charge of advertising for healthcare and beauty product firms join IZEA Worldwide CEO in discussing impact influencers can have for brands and responsibilities marketers have for content they share during NAD conference.